The Patent Finder
US

Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification

US 9,750,715 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jan 26, 2027 · High confidence

Filed Sep 9, 2009 as application 12/162,558 · Granted Sep 5, 2017
Base term, 20 years from filing
Today
20 years from filing
2007 2027
Clock starts
Jan 26, 2007
Term ends
Jan 26, 2027
Granted
Sep 5, 2017
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 26, 2007, when application PCT/US2007/002157, the earliest non-provisional in its chain, was filed (this one was filed Sep 9, 2009)Jan 26, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 26, 2027High confidence

This family

US 9,750,715this patent
Jan 2027
Jan 2027
US 9,889,113Lapsed on the fee record
Feb 2026
Feb 2026
Application 15/894,544Abandoned
not computed
not computed
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 25, 2009
Reel 23286, frame 402
Chan, Keith; Town, WinstonGloboasia, LLCAssignment of Assignor's Interest
Oct 5, 2009
Reel 23324, frame 594
Chiang, Shou ShanPanion & Biotech, Inc.Assignment of Assignor's Interest
Apr 13, 2011
Reel 26121, frame 716
Chan, Keith; Town, WinstonPanion & BF Biotech Inc.Assignment of Assignor's Interest
Apr 13, 2011
Reel 26121, frame 809
Globoasia, LLCPanion & BF Biotech Inc.Assignment of Assignor's Interest
Apr 2, 2020
Reel 52295, frame 662
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Sep 2, 2020
Reel 53671, frame 221
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecond Amended and Restated Intellectual Property Security Agreement
Sep 10, 2020
Reel 54173, frame 451
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCThird Amended and Restated Intellectual Property Security Agreement
Dec 17, 2020
Reel 54793, frame 455
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFourth Amended and Restated Intellectual Property Security Agreement
Mar 30, 2021
Reel 55776, frame 491
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFifth Amended and Restated Intellectual Property Security Agreement
Jun 11, 2021
Reel 56544, frame 468
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSixth Amended and Restated Intellectual Property Security Agreement
Sep 12, 2021
Reel 57474, frame 770
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSeventh Amended and Restated Intellectual Property Security Agreement
Dec 15, 2021
Reel 58399, frame 55
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCSecurity Interest
Jun 16, 2022
Reel 60529, frame 168
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCTenth Amended and Restated Intellectual Property Security Agreement
Aug 22, 2022
Reel 61297, frame 238
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCEleventh Amended and Restated Intellectual Property Security Agreement
Nov 29, 2022
Reel 62012, frame 561
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCTwelfth Amended and Restated Intellectual Property Security Agreement
Mar 29, 2023
Reel 63189, frame 65
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCThirteenth Amended and Restated Intellectual Property Security Agreement
Jan 4, 2024
Reel 66205, frame 143
Akebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Biopharma Credit PLCFifteenth Amended and Restated Intellectual Property Security Agreement
Jan 29, 2024
Reel 66377, frame 741
Biopharma Credit PLCAkebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jan 29, 2024
reel/frame not recorded
Biopharma Credit PLCAkebia Therapeutics, Inc.Termination and Release of Security Interest in Patents
Jan 29, 2024
reel/frame not recorded
Biopharma Credit PLCKeryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
Reel 67839, frame 134
Biopharma Credit PLCAkebia Therapeutics, Inc.; Keryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
reel/frame not recorded
Biopharma Credit PLCAkebia Therapeutics, Inc.Termination and Release of Security Interest in Patents
Jun 25, 2024
reel/frame not recorded
Biopharma Credit PLCKeryx Biopharmaceuticals, Inc.Termination and Release of Security Interest in Patents

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited